Nanomedic Technologies

Portable Wound Treatment System

Health Tech & Life Sciences
Active
Series B Lod Founded 2018
Total raised
$13.0M
Last: Convertible Debt 2022-03
Stage
Series B
Founded
2018
Headcount
14
HQ
Lod
Sector
Health Tech & Life Sciences

About

Nanomedic Technologies is a biomedical therapeutics technology company specializing in the research, development, and distribution of its innovative EHF technology and SpinCare System platform for advanced wound treatment. Nanomedics electrospinning EHF technology biomimics the natural structure of human tissue and extracellular matrix (ECM), providing a temporary skin substitute that encourages quick and efficient tissue integration and regeneration to expedite recovery and minimize potential complications. The SpinCare System delivers multiple benefits due to its portability and its ability to slowly release therapeutic and healing enhancing additives into the patients wound in accordance with clinical needs. Nanomedic is a spin-off company and subsidiary of Nicast, which is developing implantable medical devices made of electrospun polymer nanofabrics. The SpinCare system is CE certified for marketing in Europe.

Funding history · 5 rounds · $13.0M total

2022-03
Convertible Debt $3.5M
2022-02
Convertible Debt $750K
2021-12
Convertible Debt $3.0M
2020-06
Series A $2.2M
2019-05
Series A $3.3M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesNanomaterials
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

medical-technologiesburnspolymershospitalsreal-timetissue-regenerationbiomaterialsmedical-devicesnanotechnologypersonalizationfabricsvasculardoctorspain-reliefclinics